{
  "pageTitle": "Accretion Pharmaceuticals IPO Date, Price, GMP, Details",
  "ipoName": "Accretion Pharmaceuticals",
  "logo": "https://www.chittorgarh.net/images/ipo/accretion-pharmaceuticals-logo.png",
  "pageHeading": "Accretion Pharmaceuticals Limited IPO (Accretion Pharmaceuticals IPO) Detail",
  "basicDetails": {
    "ipoDate": "May 14, 2025 to May 16, 2025",
    "ipoListingDate": "Wed, May 21, 2025",
    "faceValue": "₹10 per share",
    "issuePrice": "₹101 per share",
    "lotSize": "1,200 Shares",
    "issueSize": "29,46,000 shares (aggregating up to ₹29.75 Cr)",
    "freshIssue": "29,46,000 shares (aggregating up to ₹29.75 Cr)",
    "issueType": "Bookbuilding IPO",
    "listingAt": "NSE SME",
    "marketMakerPortion": {
      "text": "1,47,600 shares",
      "maker_name": "Gretex Share Broking Private Limited",
      "maker_url": "https://www.google.com/report/ipo-market-maker-vs-listing-gain/127/247/"
    },
    "ipoOpenDate": "Wed, May 14, 2025",
    "ipoCloseDate": "Fri, May 16, 2025",
    "initiationOfRefunds": "Tue, May 20, 2025",
    "creditOfSharesToDemat": "Tue, May 20, 2025",
    "shareHoldingPreIssue": "81,70,000 shares",
    "shareHoldingPreIssueAll": [
      {
        "label": "Share Holding Pre Issue",
        "value": "81,70,000 shares"
      },
      {
        "label": "Share Holding Pre Issue",
        "value": "100.00%"
      }
    ],
    "shareHoldingPostIssue": "1,11,16,000 shares",
    "shareHoldingPostIssueAll": [
      {
        "label": "Share Holding Post Issue",
        "value": "1,11,16,000 shares"
      },
      {
        "label": "Share Holding Post Issue",
        "value": "73.48%"
      }
    ]
  },
  "tentativeDetails": {
    "ipo_date": "5 PM on May 16 2025",
    "tentative_allotment": "Mon May 19 2025",
    "initiation_of_refunds": "Tue May 20 2025",
    "credit_of_shares_to_demat": "Tue May 20 2025"
  },
  "lotSize": {
    "summary": "Investors can bid for a minimum of 1200 shares and in multiples thereof. The following table depicts the minimum and maximum investment by Retail Investors and HNI in terms of shares and amount.",
    "applications": {
      "retail_min": {
        "application": "Retail (Min)",
        "lots": "1",
        "shares": "1200",
        "amount": "121200"
      },
      "retail_max": {
        "application": "Retail (Max)",
        "lots": "1",
        "shares": "1200",
        "amount": "121200"
      },
      "hni_min": {
        "application": "HNI (Min)",
        "lots": "2",
        "shares": "2400",
        "amount": "242400"
      },
      "lot_size": {
        "application": "Lot Size Calculator"
      }
    },
    "calculator_link": {
      "text": "Lot Size Calculator",
      "url": "/ipo-hni-funding-cost-calculator/accretion-pharmaceuticals-ipo/2159/"
    }
  },
  "promoterHolding": {
    "promoters": "The promoters of the company are Mr. Mayur Popatlal Sojitra Mr. Harshad Nanubhai Rathod Mr. Vivek Ashok Kumar Patel and Mr. Hardik Mukundbhai Prajapati.",
    "holdings": {
      "share_holding_pre_issue": "100.00%",
      "share_holding_post_issue": "73.48%"
    },
    "note": "The value will be calculated using Equity Dilution = Share Holding Pre Issue - Share Holding Post Issue"
  },
  "about": {
    "details": "<p>Incorporated in 2012, Accretion Pharmaceuticals Limited is a pharmaceutical company that manufactures and sells tablets, capsules, and other healthcare products.</p>\n<p>The company also offers contract manufacturing services. The Company manufactures and markets Tablets, Capsules, Oral Liquids, External Preparations (Ointment, Cream, Gel, Lotion, Medicated Shampoo, Mouthwash, Dusting Powder), and Oral Powder (Sachet, Dry Syrup).</p>\n<p>The company also holds ISO 9001:2015, ISO 14001:2015, and ISO 22000:2005 certifications, reflecting its dedication to quality and environmental management systems.</p>\n<p>The company's manufacturing unit is located in Ahmedabad, Sanand, Gujarat.</p>\n<p>The company has expanded its global footprint, marking its presence in more than 20 countries, including regions in Africa, Southeast Asia, and the Middle East.</p>\n<p>Product Portfolio and Services</p>\n<ul>\n<li><strong>Tablets and Capsules</strong> – Covering antibiotics, anti-inflammatory, pain management, cardiovascular, and gastrointestinal medicines.</li>\n<li><strong>Oral Liquids and Syrups</strong> – Used for respiratory, pediatric, and digestive treatments.</li>\n<li><strong>External Preparations</strong> – Including medicated lotions, gels, ointments, and dusting powders for skin care and dermatological treatments.</li>\n<li><strong>Ayurvedic and Herbal Products</strong> – Focused on natural wellness solutions for immunity, digestion, and general health.</li>\n</ul>\n<p>As of January 2025, the company has 83 employees (including 4 Executive Directors) on its payroll.</p>\n<p><strong>Competitive Strength:</strong></p>\n<ul>\n<li>Experienced Promoters and Management Team.</li>\n<li>Long-standing relationship with clients and suppliers.</li>\n<li>Focus on providing quality products.</li>\n<li>Management has built a supply chain and customer relations, creating goodwill and trust.</li>\n</ul>"
  },
  "contactDetails": {
    "phone": "+91-97148 82929",
    "email": "compliance@accretionpharma.com",
    "full_address": "Accretion Pharmaceuticals Limited, 29 Xcelon Ind Park 1, B/h Intas Pharmaceuticals Vasna Chacharvad, Sanand",
    "website": "https://accretionpharma.com/"
  },
  "registrarDetails": {
    "name": "Kfin Technologies Limited",
    "phone": "04067162222 04079611000",
    "email": "apl.ipo@kfintech.com",
    "website": "https://kosmic.kfintech.com/ipostatus/"
  },
  "leadManagers": [
    {
      "name": "Jawa Capital Services Private Limited",
      "url": "/report/ipo-lead-manager-review/112/421/",
      "performance_link": "/report/ipo-lead-manager-vs-listing-gain/99/all/421/"
    }
  ],
  "leadManagerReports": [
    {
      "text": "IPO Lead Manager Performance Summary",
      "url": "/report/ipo_lead_manager_performance_tracker/19/"
    },
    {
      "text": "IPO Lead Manager Performance Tracker",
      "url": "/report/ipo-lead-manager-vs-listing-gain/99/all/"
    }
  ],
  "listingDetails": {
    "pre_open_links": [
      {
        "text": "Pre-Open Session - NSE",
        "url": "https://www.nseindia.com/market-data/new-stock-exchange-listings-today"
      }
    ],
    "ipo_date": "May 21 2025",
    "nse_symbol": "ACCPL",
    "isin": "INE0T8T01010",
    "final_issue_price": "101 per share"
  },
  "faqs": [
    {
      "question": "What is the Accretion Pharmaceuticals IPO?",
      "answer": "<div itemprop=\"text\"><p>Accretion Pharmaceuticals IPO<!-- --> is a <b>SME<!-- --> <!-- -->IPO<!-- --> of <!-- -->2946000<!-- --> equity shares</b> of the face value of ₹<!-- -->10<!-- --> aggregating up to ₹<!-- -->29.75<!-- --> Crores. The issue is priced at <span>₹101 per share</span>. The minimum order quantity is <!-- -->1200<!-- -->.</p><p>The <!-- -->IPO<!-- --> <b>opens on <!-- -->May 14, 2025</b>, and <b>closes on <!-- -->May 16, 2025</b>.</p><p>Kfin Technologies Limited<!-- --> is the registrar for the <!-- -->IPO<!-- -->. The shares are proposed to be listed on <!-- -->NSE SME<!-- -->.</p></div>"
    },
    {
      "question": "How to apply in Accretion Pharmaceuticals IPO through Zerodha?",
      "answer": "<div itemprop=\"text\"><p>Zerodha customers can apply online in <!-- -->Accretion Pharmaceuticals IPO<!-- --> using UPI as a payment gateway. Zerodha customers can apply in <!-- -->Accretion Pharmaceuticals IPO<!-- --> by login into Zerodha Console (back office) and submitting an IPO application form.</p><p><strong>Steps to apply in <!-- -->Accretion Pharmaceuticals IPO<!-- --> through Zerodha</strong></p><ol><li>Visit the Zerodha website and login to Console.</li><li>Go to Portfolio and click the IPOs link.</li><li>Go to the '<!-- -->Accretion Pharmaceuticals IPO<!-- -->' row and click the 'Bid' button.</li><li>Enter your UPI ID, Quantity, and Price.</li><li>Submit IPO application form.</li><li>Visit the UPI App (net banking or BHIM) to approve the mandate.</li></ol><p>Visit <a href=\"/broker/zerodha/ipo/18/\" title=\"Zerodha IPO Application Process Review\">Zerodha IPO Application Process Review</a> for more detail.</p></div>"
    },
    {
      "question": "When Accretion Pharmaceuticals IPO will open?",
      "answer": "<div itemprop=\"text\"><p>The Accretion Pharmaceuticals IPO opens on May 14, 2025 and closes on May 16, 2025.</p></div>"
    },
    {
      "question": "What is the lot size of Accretion Pharmaceuticals IPO?",
      "answer": "<div itemprop=\"text\"><p>Accretion Pharmaceuticals IPO<!-- --> <b>lot size is <!-- -->1200</b>, and the <b>minimum amount required is <span>₹1,21,200</span></b>.</p></div>"
    },
    {
      "question": "How to apply for Accretion Pharmaceuticals IPO?",
      "answer": "<div itemprop=\"text\"><p>You can apply in <!-- -->Accretion Pharmaceuticals IPO<!-- --> online using either <a href=\"/article/upi-payment-option-ipo-application-explained/382/\">UPI</a> or ASBA as a payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO application is offered by brokers who don't offer banking services. Read more detail about applying IPO online through <a href=\"/broker/zerodha/ipo/18/\" title=\"Zerodha IPO Review\"><b>Zerodha</b></a>, <a href=\"/broker/upstox/ipo/33/\" title=\"Upstox IPO Review\">Upstox</a>, <a href=\"/broker/5paisa/ipo/4/\" title=\"5Paisa IPO Review\">5Paisa</a>, <a href=\"/broker/edelweiss_broking/ipo/34/\" title=\"Nuvama IPO Review\">Nuvama</a>, <a href=\"/broker/hdfc-securities/ipo/6/\" title=\"HDFC Bank IPO Review\">HDFC Bank</a>, and <a href=\"/broker/sbi-capital/ipo/19/\" title=\"SBI Capital IPO Review\">SBI Bank</a>.</p></div>"
    },
    {
      "question": "When is Accretion Pharmaceuticals IPO allotment?",
      "answer": "<div itemprop=\"text\"><p>The finalization of Basis of Allotment for <!-- -->Accretion Pharmaceuticals IPO<!-- --> will be done on <!-- -->Monday, May 19, 2025<!-- -->, and the allotted shares will be credited to your demat account by <!-- -->Tuesday, May 20, 2025<!-- -->. Check the <a href=\"/ipo_allotment_status/accretion-pharmaceuticals-ipo/2159/\" title=\"Accretion Pharmaceuticals IPO Allotment Status\">Accretion Pharmaceuticals IPO<!-- --> allotment status</a>.</p></div>"
    },
    {
      "question": "When is Accretion Pharmaceuticals IPO listing date?",
      "answer": "<div itemprop=\"text\"><p>The <!-- -->Accretion Pharmaceuticals IPO<!-- --> listing date is on <b>Wednesday, May 21, 2025</b>.</p></div>"
    }
  ],
  "recommendationSummary": {
    "recommendations": {
      "brokersbrokers": {
        "subscribe": "1",
        "neutral": "0",
        "avoid": "0"
      },
      "membersmembers": {
        "subscribe": "0",
        "neutral": "0",
        "avoid": "0"
      }
    },
    "links": [
      {
        "text": "Read All Reviews",
        "url": "/ipo-recommendation/accretion-pharmaceuticals-ipo/2159/"
      },
      {
        "text": "Post Your Review",
        "url": "#"
      },
      {
        "text": "Manage Reviews",
        "url": "#"
      }
    ]
  },
  "prospectusLinks": [
    {
      "text": "Accretion Pharmaceuticals IPO DRHP",
      "url": "https://nsearchives.nseindia.com/emerge/corporates/content/trampariya_17012025102852_DRHP_AccretionFinal.pdf"
    },
    {
      "text": "Accretion Pharmaceuticals IPO RHP",
      "url": "https://archives.nseindia.com/content/ipo/RHP_ACCPL.zip"
    },
    {
      "text": "Anchor Investors in Accretion Pharmaceuticals IPO",
      "url": "https://www.chittorgarh.net/reports/anchor-investor/accretionpharmaceuticals_anchorallocationreport.pdf"
    }
  ],
  "reservation": {
    "summary": "Accretion Pharmaceuticals IPO offers total 2946000 shares. Out of which 141600 (4.81%) allocated to QIB 1222800 (41.51%) allocated to NII 1222800 (41.51%) allocated to RII and 211200 (7.17%) allocated to Anchor investors.",
    "allocation": [
      {
        "investor_category": "Anchor Investor Shares Offered",
        "shares_offered": "211200 (7.17%)"
      },
      {
        "investor_category": "Market Maker Shares Offered",
        "shares_offered": "147600 (5.01%)"
      },
      {
        "investor_category": "QIB Shares Offered",
        "shares_offered": "141600 (4.81%)"
      },
      {
        "investor_category": "NII (HNI) Shares Offered",
        "shares_offered": "1222800 (41.51%)"
      },
      {
        "investor_category": "Retail Shares Offered",
        "shares_offered": "1222800 (41.51%)"
      },
      {
        "investor_category": "Total Shares Offered",
        "shares_offered": "2946000 (100%)"
      }
    ]
  },
  "anchorInvestors": {
    "summary": "Accretion Pharmaceuticals IPO raises Rs 2.13 crore from anchor investors. Accretion Pharmaceuticals IPO Anchor bid date is May 13 2025. Accretion Pharmaceuticals IPO Anchor Investors list",
    "list_link": {
      "text": "Accretion Pharmaceuticals IPO Anchor Investors list",
      "url": "https://www.chittorgarh.net/reports/anchor-investor/accretionpharmaceuticals_anchorallocationreport.pdf"
    },
    "details": {
      "ipo_date": "August 17 2025",
      "shares_offered": "211200",
      "anchor_portion_size": "2.13"
    }
  },
  "additionalTables": [
    {
      "heading": "Accretion Pharmaceuticals Limited Financial Information (Restated Consolidated)",
      "sanitizedHeading": "financials",
      "headers": [
        "Period Ended",
        "31 Dec 2024",
        "31 Mar 2024",
        "31 Mar 2023",
        "31 Mar 2022"
      ],
      "rows": [
        [
          "Assets",
          "39.99",
          "27.05",
          "20.58",
          "17.74"
        ],
        [
          "Revenue",
          "35.75",
          "33.94",
          "29.53",
          "22.58"
        ],
        [
          "Profit After Tax",
          "5.24",
          "3.88",
          "0.10",
          "0.08"
        ],
        [
          "Net Worth",
          "13.58",
          "5.35",
          "3.84",
          "3.08"
        ],
        [
          "Reserves and Surplus",
          "5.41",
          "1.35",
          "0.00",
          "0.00"
        ],
        [
          "Total Borrowing",
          "13.79",
          "13.48",
          "8.47",
          "7.61"
        ]
      ]
    },
    {
      "heading": "Accretion Pharmaceuticals IPO Details",
      "sanitizedHeading": "accretion_pharmaceuticals",
      "headers": [
        "KPI",
        "Values"
      ],
      "rows": [
        [
          "ROE",
          "72.47%"
        ],
        [
          "ROCE",
          "36.73%"
        ],
        [
          "Debt/Equity",
          "2.52"
        ],
        [
          "RoNW",
          "72.47%"
        ],
        [
          "PAT Margin",
          "11.51"
        ],
        [
          "Price to Book Value",
          "7.55"
        ]
      ]
    },
    {
      "heading": "Accretion Pharmaceuticals IPO Details",
      "sanitizedHeading": "accretion_pharmaceuticals",
      "headers": [
        null,
        "Pre IPO",
        "Post IPO"
      ],
      "rows": [
        [
          "EPS (Rs)",
          "4.74",
          "6.28"
        ],
        [
          "P/E (x)",
          "21.29",
          "16.08"
        ]
      ]
    },
    {
      "heading": "Accretion Pharmaceuticals IPO Details",
      "sanitizedHeading": "accretion_pharmaceuticals",
      "headers": [
        "S.No.",
        "Objects of the Issue",
        "Expected Amount (in Millions)"
      ],
      "rows": [
        [
          "1",
          "Capital expenditure towards purchase of new equipment/ machineries etc.",
          "26.97"
        ],
        [
          "2",
          "Capital expenditure towards upgradation of existing manufacturing facility",
          "46.56"
        ],
        [
          "3",
          "Repayment/prepayme nt of certain borrowings availed by the Company",
          "9.92"
        ],
        [
          "4",
          "Funding working capital requirements",
          "146.80"
        ],
        [
          "5",
          "General Corporate Purpose",
          null
        ]
      ]
    }
  ],
  "_metadata": {
    "sectionsAvailable": {
      "basicDetails": true,
      "tentativeSchedule": true,
      "lotSize": true,
      "timeline": false,
      "kpi": true,
      "financials": true,
      "promoterHolding": true,
      "objectives": false,
      "about": true,
      "subscriptionStatus": false,
      "contactDetails": true,
      "registrarDetails": true,
      "leadManagers": true,
      "listingDetails": true,
      "listingDayTrading": false,
      "faqs": true,
      "recommendationSummary": true,
      "prospectusLinks": true,
      "reservation": true,
      "anchorInvestors": true
    },
    "scrapedAt": "2025-05-20T17:51:50.818Z",
    "sourceUrl": "https://www.chittorgarh.com/ipo/accretion-pharmaceuticals-ipo/2159/"
  },
  "subscriptionHistory": {
    "overall_subscription": {
      "qib": {
        "category": "Qualified Institutional",
        "subscription_times": "12.14"
      },
      "non_institutional": {
        "category": "Non Institutional",
        "subscription_times": "4.28"
      },
      "retail": {
        "category": "Retail Individual",
        "subscription_times": "10.54"
      },
      "total": {
        "category": "Total Subscription",
        "subscription_times": "7.67"
      }
    },
    "day_wise_subscription": [],
    "total_applications": "",
    "subscription_notes": []
  }
}